Valuation: Biogen Inc.

Market Cap 3.07TCr 2.67TCr 2.48TCr 2.29TCr 4.3TCr 2,93300Cr 4.38TCr 29TCr 11TCr 1,45700Cr 12TCr 11TCr 4,89900Cr P/E 2026 *
38.1x
P/E 2027 * 18.3x
Enterprise Value 3.58TCr 3.11TCr 2.89TCr 2.66TCr 5.02TCr 3,41800Cr 5.11TCr 34TCr 13TCr 1,69800Cr 13TCr 13TCr 5,70900Cr EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.1x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week-0.37%
Current month+7.51%
1 month+7.51%
3 months+13.54%
6 months+19.46%
Current year+18.79%
1 week 176.06
Extreme 176.06
189.72
1 month 165.54
Extreme 165.54
193
Current year 134.7
Extreme 134.7
193
1 year 108.8
Extreme 108.8
193
3 years 99
Extreme 99
255.4
5 years 99
Extreme 99
317.45
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-6.11%-0.37% - - 3.07TCr
+6.17%+13.26%+33.13%-1.04% 7.51TCr
-13.51%-10.70%+17.04%+172.20% 4.76TCr
+3.25%+52.70%+52.70%+52.70% 4.95TCr
-3.81%+6.32%-54.61%-54.17% 4.29TCr
-3.23%+5.40%+58.59%+94.94% 2.49TCr
+6.29%+1.58%+80.16%-51.19% 2.3TCr
-1.48%-3.56%-11.48%+150.72% 1.96TCr
-0.13%+3.10%+69.03%+129.42% 1.72TCr
-1.68%-0.95%+80.05%+138.64% 1.61TCr
Average -0.64%+2.57%+36.07%+70.25% 3.51TCr
Weighted average by Cap. -0.35%+3.67%+28.85%+53.80%

Financials

2026 *2027 *
Net sales 1.04TCr 901.57Cr 837.22Cr 772.12Cr 1.45TCr 99TCr 1.48TCr 9.91TCr 3.88TCr 49TCr 3.9TCr 3.81TCr 1,65500Cr 1.06TCr 918.4Cr 852.85Cr 786.53Cr 1.48TCr 1,00900Cr 1.51TCr 10TCr 3.95TCr 50TCr 3.97TCr 3.88TCr 1,68600Cr
Net income 94Cr 82Cr 76Cr 70Cr 132.39Cr 9.02TCr 134.78Cr 902.21Cr 353.25Cr 4.48TCr 354.8Cr 347.03Cr 15TCr 196.81Cr 170.95Cr 158.75Cr 146.4Cr 275.77Cr 19TCr 280.77Cr 1.88TCr 735.85Cr 9.33TCr 739.08Cr 722.9Cr 31TCr
Net Debt 508.12Cr 441.35Cr 409.85Cr 377.98Cr 711.99Cr 49TCr 724.88Cr 4.85TCr 1.9TCr 24TCr 1.91TCr 1.87TCr 81TCr 203.59Cr 176.84Cr 164.22Cr 151.45Cr 285.28Cr 19TCr 290.45Cr 1.94TCr 761.22Cr 9.65TCr 764.56Cr 747.82Cr 32TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
30/26/30 €178.12 -6.11% 154
29/26/29 €189.72 +6.66% 390
28/26/28 €177.88 -0.33% 0
27/26/27 €178.46 +0.35% 31
24/26/24 €177.84 -0.53% 31
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
207.93USD
Average target price
233.87USD
Spread / Average Target
+12.47%

Quarterly revenue - Rate of surprise